ASSURE WCD Clinical Evaluation - Detection and Safety Study
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT03887052
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose other
- Phase
- Not applicable
- Enrolled
- 130 participants
- Sponsor
- Kestra Medical Technologies, Inc.
- Registry
-
NCT03887052
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03887052. Allocation not applicable; no masking; primary purpose other. Start 2019-03-20 (actual); primary completion 2019-06-18 (actual). Results posted on 2023-10-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ASSURE WCD Clinical Evaluation - Detection and Safety Study
- Acronym
- ACE-DETECT
- Condition
- Cardiac Arrest, Sudden
- Intervention (Device)
- ASSURE™ Wearable Cardioverter Defibrillator (WCD)
- Lead sponsor
- Kestra Medical Technologies, Inc.
- Collaborator
- Regulatory and Clinical Research Institute Inc
Record details
- Record id
cardio:ct-nct03887052- Content hash
ae5d0bddbcb63741b053a0324d6a2f990c88d37dcb3ca70e633eb76da4056fd7